The Effects of modified-release fampridine on upper limb impairment in multiple sclerosis

被引：0
|
作者：
Simpson, M. [1 ]
Churilov, L. [2 ]
Bardsley, B. [1 ]
Heriot, E. [1 ]
Dimovitis, J. [1 ]
Carey, L. [3 ]
Macdonell, R. [1 ]
机构：
[1] Univ Melbourne, Austin Hlth, Melbourne, Vic, Australia
[2] Univ Melbourne, Stat, Melbourne, Vic, Australia
[3] Univ Melbourne, Melbourne, Vic, Australia
来源：
MULTIPLE SCLEROSIS JOURNAL | 2016年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1294
引用
收藏
页码：685 / 685
页数：1
相关论文
共 50 条
  • [21] Dose comparison trial of sustained-release fampridine in multiple sclerosis
    Goodman, A. D.
    Brown, T. R.
    Cohen, J. A.
    Krupp, L. B.
    Schapiro, R.
    Schwid, S. R.
    Cohen, R.
    Marinucci, L. N.
    Blight, A. R.
    NEUROLOGY, 2008, 71 (15) : 1134 - 1141
  • [22] A tailored exercise of manipulation of virtual tools to treat upper limb impairment in Multiple Sclerosis
    Basteris, Angelo
    De Luca, Alice
    Sanguineti, Vittorio
    Solaro, Claudio
    Mueller, Margit
    Carpinella, Ilaria
    Cattaneo, Davide
    Bertoni, Rita
    Ferrarin, Maurizio
    2011 IEEE INTERNATIONAL CONFERENCE ON REHABILITATION ROBOTICS (ICORR), 2011,
  • [23] Modeling the cost-effectiveness of prolonged-release fampridine for the treatment of walking impairment in patients with multiple sclerosis in Sweden
    Acosta, Carlos
    Gianinazzi, Mattia
    Dort, Thibaut
    Armstrong, Nigel
    Ryder, Steve
    Lundqvist, Thomas
    Ekelund, Mats
    Lycke, Jan
    JOURNAL OF MEDICAL ECONOMICS, 2021, 24 (01) : 770 - 780
  • [24] Prolonged-release fampridine: a guide to its use in multiple sclerosis in the EU
    Katherine A. Lyseng-Williamson
    Drugs & Therapy Perspectives, 2012, 28 (12) : 1 - 4
  • [25] Recommendations for the Use of Prolonged-Release Fampridine in Patients with Multiple Sclerosis (MS)
    Preiningerova, Jana Lizrova
    Baumhackl, Ulf
    Csepany, Tunde
    Czaplinski, Adam
    Deisenhammer, Florian
    Derfuss, Tobias
    Fabjan, Tanja H.
    Fazekas, Franz
    Fuchs, Siegrid
    Havrdova, Eva
    Ledinek, Alenka Horvath
    Illes, Zsolt
    Jazbec, Sasa Sega
    Klimova, Eleonora
    Komoly, Samuel
    Kurca, Egon
    Linnebank, Michael
    Lisy, Lubomir
    Mares, Jan
    Prochazkova, Lubica
    Csilla, Rozsa
    Szilasiova, Jarmila
    Stourac, Pavel
    Talab, Radomir
    Turcani, Peter
    Vachova, Marta
    Vecsei, Laszlo
    Vodusek, David
    Zapletalova, Olga
    Berger, Thomas
    CNS NEUROSCIENCE & THERAPEUTICS, 2013, 19 (05) : 302 - 306
  • [26] Sustained-release fampridine and the role of ion channel dysfunction in multiple sclerosis
    Krishnan, Arun V.
    Kiernan, Matthew C.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (04) : 385 - 391
  • [27] Antihypertensive effects of nifedipine and changing for modified-release formula
    Kuwajima, Iwao
    DRUGS, 2006, 66 : 7 - 9
  • [28] Clinical experience using prolonged release fampridine in the symptomatic treatment of multiple sclerosis
    Vaz, Soraia
    Barros, Ariana
    Capela, Carlos
    Sequeira, Joao
    Dias, Sara
    Morgado, Joana
    Sousa, Ary
    Bras, Pedro
    Pedrosas, Rui
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 60 - 60
  • [29] Assessing upper limb function in multiple sclerosis
    Lamers, Ilse
    Feys, Peter
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (07) : 775 - 784
  • [30] Upper limb entrapment neuropathies in multiple sclerosis
    Yin, Han
    Nair, Krishnan P. S.
    Rao, Dasappaiah G.
    Hariharan, Sankaranarayanan
    Spencer, Amy
    Baster, Kathleen
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2020, 6 (02)
12345